Nuru Noor | Health Professions | Best Researcher Award

Dr. Nuru Noor | Health Professions | Best Researcher Award

Clinical Lecturer University of Cambridge United Kingdom

Dr. Nuru Noor, a distinguished academic gastroenterologist, combines clinical expertise in Inflammatory Bowel Disease (IBD) with an academic focus on innovative drug development and clinical trials. Based at the University of Cambridge and Cambridge University Hospitals, UK, Dr. Noor strives to improve the quality of life for IBD patients by translating research findings into impactful clinical applications. 🌟

Profile

Google Scholar

Orcid

Education

Dr. Noor holds an impressive array of qualifications: a BSc, BMBS, MPhil, MRCP, PhD, and a Postgraduate Certificate in Medical Education (PGC Med Ed). Their academic journey reflects a strong commitment to advancing both clinical and academic excellence. 🎓

Experience

Dr. Noor is currently a Clinical Lecturer in Gastroenterology at the University of Cambridge and a Postdoctoral Researcher in Clinical Trials at the Medical Research Council (MRC) Clinical Trials Unit, University College London. They serve as Principal Investigator for PROFILE, a multi-center RCT for Crohn’s disease patients, and contribute to several prestigious committees, including NICE medical expert reviews and the NIHR EME funding committee. 🩺

Research Interests

Dr. Noor’s research focuses on developing innovative approaches to drug development and clinical trials, particularly for IBD. This includes precision medicine, trial methodology, and improving treatment outcomes for patients through cutting-edge translational research. 🔬

Awards

Dr. Noor’s outstanding contributions have been recognized with several prestigious awards, including:

  • British Society of Gastroenterology Clinical Research Award (2024) 🏆
  • Academy of Medical Sciences Best Research Abstract Award (2024)
  • ECCO Investigator-Initiated Study of the Year Team Award (2024)
  • Royal College of Physicians of Edinburgh Croom Medal (2022)

Publications Top Notes:

Dr. Noor has authored over 60 PubMed-indexed publications and contributed to 3 book chapters. Their works span highly regarded journals in gastroenterology, clinical trials, and IBD research. Key publications include:

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …

ECCO guidelines on therapeutics in ulcerative colitis: medical treatment

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global …

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): a multicentre, open …

Maria Yavropoulou | Health Professions | Best Researcher Award

Dr. Maria Yavropoulou | Health Professions | Best Researcher Award

Endocrinology Consultant LAIKO University Hospital, Medicine school, national and Kapodistrian University of Athens Greece

Dr. Maria Yavropoulou is a distinguished Endocrinology Consultant at the Endocrinology Unit of the 1st Department of Propaedeutic and Internal Medicine, Medical School of the National and Kapodistrian University of Athens (NKUA). Based at LAIKO University Hospital in Athens, Greece, she specializes in managing endocrine disorders, with a keen focus on rare diseases of calcium and phosphate metabolism.

Profile

Orcid

Education 🎓

  • Medical Degree: Aristotle University of Thessaloniki (AUTh), Greece.
  • Endocrinology Specialization: AHEPA University Hospital, Thessaloniki.
  • Advanced Training: University of Leiden, Netherlands (LUMC), under Prof. Socrates Papapoulos; University of Arkansas, USA (UAMS), under Prof. Stavros Manolagas.
  • Ph.D.: Bone metabolism diseases, Aristotle University of Thessaloniki (AUTh).
  • Master’s Degrees:
    • “Translational Research in Molecular Biology and Genetics” (NKUA).
    • “Epidemiology – Research Methodology in Biomedical Sciences in Clinical Practice and Public Health” (NKUA).

Experience 🩺

  • Consultant actively managing all endocrine diseases, emphasizing rare calcium and phosphate metabolism disorders.
  • Deputy Head (since 2019): Center for Expertise of Rare Disorders of Calcium and Phosphate Metabolism (C.E.R.E.D), LAIKO Hospital.
  • Patient and Quality Coordinator: Center for Expertise for Adult Langerhans Histiocytosis, Athens.
  • Prestigious Memberships: Member of European Calcified Tissue Society, Steering Committee Member of ESE Educational Programme on Rare Disorders.

Research Interests 🧬

Dr. Yavropoulou’s research focuses on:

  • Bone metabolism and associated molecular mechanisms.
  • Diabetes and its intersection with endocrine disorders.
  • Cortisol production and its impact on rheumatoid arthritis.

Awards 🏆

Dr. Yavropoulou’s exemplary work has earned her numerous accolades, including:

  1. Jens Sandahl Christiansen Award (2020) – European Society of Endocrinology.
  2. G. TOLIS Award (2019) – Hellenic Endocrine Society.
  3. D. IKKOS Awards (2021, 2022) – Clinical Research, Hellenic Endocrine Society.
  4. EJE Rising Star Award (2022) – European Journal of Endocrinology.
  5. Excellence Scholarship in Ph.D. Thesis (2009-2010) – Aristotle University of Thessaloniki.

Publications Top Notes: 📚

Dr. Yavropoulou has authored numerous impactful publications (134 total, 3164 citations, h-index: 29). Selected works include:

The Association of Vitamin D Receptor Polymorphisms with COVID-19 Severity (2024) – Nutrients.

Diurnal Production of Cortisol and Treatment Response in Rheumatoid Arthritis (2024) – RMD Open.

Transient Osteoporosis Following Denosumab Discontinuation (2024) – Osteoporosis International.

Nocebo-Associated Treatment Discontinuation in Anti-Osteoporotic Drugs (2024) – Maturitas.

Immune System Effects on the Endocrine System (2023) – Endotext.